Paydirt
DNTH
Ticker

Dianthus Therapeutics, Inc.

DNTH · Healthcare · Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoi…

Dianthus Therapeutics, Inc. (DNTH), in the Healthcare sector, has 17 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 0 purchases and 17 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Sep 17 and filed Sep 18. The most active filer was Ryan Savitz with 5 filings.

Add to watchlist
Filings, ttm
17
0 buys · 17 sells
Traders, ttm
8
8 insiders
Volume, ttmiDollar value disclosed in the window
$70.3M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Sep 17
Filed Sep 18
ADViAverage daily dollar volume
$122.5M
market data
Share price · 12M
$108 (+186.3%)
$116$74.44$32.92Sep 22 2025Mar 16Sep 4

Adjusted for splits and dividends.

Volume by month
$21.1M$10.5M$0Oct 2024Apr 2025Oct 2025Apr 2026Sep 2025 · sells $700KNov 2025 · sells $7.4MDec 2025 · sells $904KMar 2026 · sells $18.4MApr 2026 · sells $10.2MJun 2026 · sells $4.8MJul 2026 · sells $3.2MAug 2026 · sells $21.1MSep 2026 · sells $4.4M
Buys $0 Sells $71.0M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
RS Ryan Savitz EVP, CFO & CBO 5 filings SR Simrat Randhawa EVP, Head of R&D 4 filings EC Edward Carr CHIEF ACCOUNTING OFFICER 2 filings MG Marino Garcia CEO AND PRESIDENT 2 filings AV Adam M Veness SVP, General Counsel and Sec. 2 filings AM Anne McGeorge Director 1 filing SR Simon Read Director 1 filing PS Paula Soteropoulos Director 1 filing
Recent filings
Edward CarrSALE CHIEF ACCOUNTING OFFICER $2.0M
19,300 sh across 4 lots
Exec Sep 17
Filed Sep 18 · 4:36 PM ET Simrat RandhawaSALE EVP, Head of R&D $2.5M
23,124 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 4:30 PM ET Simon ReadSALE Director $327K
2,778 sh × $117.55
Exec Aug 19
Filed Aug 19 · 6:02 PM ET Anne McGeorgeSALE Director $767K
7,050 sh across 4 lots
Exec Aug 10
Filed Aug 11 · 5:15 PM ET Adam M VenessSALE SVP, General Counsel and Sec. $2.1M
19,384 sh across 2 lots
Exec Aug 7
Filed Aug 11 · 5:08 PM ET Marino GarciaSALE CEO AND PRESIDENT $17.9M
165,200 sh across 6 lots
Exec Aug 7
Filed Aug 7 · 6:30 PM ET Ryan SavitzSALE EVP, CFO & CBO $3.2M
31,249 sh across 3 lots
Exec Jul 9
Filed Jul 13 · 5:00 PM ET Adam M VenessSALE SVP, General Counsel and Sec. $2.4M
30,000 sh across 2 lots
Exec Jun 17
Filed Jun 18 · 5:30 PM ET Simrat RandhawaSALE EVP, Head of R&D $2.4M
26,530 sh across 3 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET Ryan SavitzSALE EVP, CFO & CBO $739K
8,224 sh × $89.84
Exec Apr 9
Filed Apr 10 · 5:30 PM ET Ryan SavitzSALE EVP, CFO & CBO $9.4M
113,567 sh across 7 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET Paula SoteropoulosSALE Director $2.2M
27,594 sh × $78.05
Exec Mar 24
Filed Mar 26 · 5:30 PM ET Simrat RandhawaSALE EVP, Head of R&D $2.8M
33,830 sh × $81.48
Exec Mar 12
Filed Mar 13 · 5:30 PM ET Edward CarrSALE CHIEF ACCOUNTING OFFICER $3.5M
43,182 sh across 3 lots
Exec Mar 12
Filed Mar 13 · 5:30 PM ET Marino GarciaSALE CEO AND PRESIDENT $9.9M
121,818 sh across 3 lots
Exec Mar 12
Filed Mar 13 · 5:30 PM ET Ryan SavitzSALE CFO & CBO $904K
20,000 sh × $45.18
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET Simrat RandhawaSALE EVP, Head of R&D $7.4M
196,538 sh across 4 lots
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET Ryan SavitzSALE CFO & CBO $700K
20,000 sh × $35.00
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET